Style | Citing Format |
---|---|
MLA | Sajadian A, et al.. "Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial." Iranian Journal of Breast Diseases, vol. 16, no. 4, 2024, pp. 34-49. |
APA | Sajadian A, Motaharinasab A, Heydari L, Farokhi D, Haghighat S, Hashemi E (2024). Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial. Iranian Journal of Breast Diseases, 16(4), 34-49. |
Chicago | Sajadian A, Motaharinasab A, Heydari L, Farokhi D, Haghighat S, Hashemi E. "Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial." Iranian Journal of Breast Diseases 16, no. 4 (2024): 34-49. |
Harvard | Sajadian A et al. (2024) 'Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial', Iranian Journal of Breast Diseases, 16(4), pp. 34-49. |
Vancouver | Sajadian A, Motaharinasab A, Heydari L, Farokhi D, Haghighat S, Hashemi E. Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial. Iranian Journal of Breast Diseases. 2024;16(4):34-49. |
BibTex | @article{ author = {Sajadian A and Motaharinasab A and Heydari L and Farokhi D and Haghighat S and Hashemi E}, title = {Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial}, journal = {Iranian Journal of Breast Diseases}, volume = {16}, number = {4}, pages = {34-49}, year = {2024} } |
RIS | TY - JOUR AU - Sajadian A AU - Motaharinasab A AU - Heydari L AU - Farokhi D AU - Haghighat S AU - Hashemi E TI - Effect of Logotherapy Treatment Alone or in Combination With Yoga on Anxiety, Depression, and Happiness After Breast Cancer: A Clinical Trial JO - Iranian Journal of Breast Diseases VL - 16 IS - 4 SP - 34 EP - 49 PY - 2024 ER - |